20-Nov-2013 - Almac says it is in a unique position to offer Carbon-14 ADME radiolabeling for the growing antibody-drug conjugate (ADC) market and has already performed the service on a Pfizer candidate....
20-Nov-2013 - CRO Harlan Laboratories is partnering with BioXpert, a company specializing in laboratory animal science and services, to expand Harlan’s contract breeding services into Benelux, Germany. This was the second expansion in Europe...
18-Nov-2013 - Covance’s central labs unit has teamed up with NeoGenomics in a second genetics-focused collaboration in as many weeks.
07-Nov-2013 - Third quarter growth in preclinical services was due to gain in market share and demand from Big Pharma, Charler River Laboratories (CRL) says as it reports solid Q3 earnings.
07-Nov-2013 - Covance and Pathoquest have announced an exclusive agreement to collaborate in providing next-generation sequencing (NGS)-based biosafety assessments.
06-Nov-2013 - Wuxi Pharmatech has agreed to licence patient-derived xenograft (PDX) mouse models from the Mayo Clinic's Center for Individualized Medicine.
30-Oct-2013 - Covance produced solid Q3 results as expected by analysts though whether the CRO can fire both early and late stage development cylinders at once remains a question.
17-Oct-2013 - Early stage drug developer Charles River Laboratories is pushing further into Asia with its purchase of the microbiology subcontractor BRASS Pte Ltd. Terms of the acquisition were not disclosed.
14-Oct-2013 - Discovery CRO Crown Biosciences has partnered with X-ray drug research specialist Xstrahl Life Sciences in a deal designed to make preclinical models that more accurately reflect clinical use of radiotherapy.
08-Oct-2013 - Enteris has secured its first partnership to develop metabolic peptides for Nordic Bioscience using an oral delivery platform it says offers unparalleled bioavailability.
01-Oct-2013 - Preclinical CRO Cyprotex has set up a laboratory at a former AstraZenca R&D facility that ceased drug development operations earlier this year .
24-Sep-2013 - Molecular Profiles has been chosen to develop topical and solid dose formulations of a preclinical psoriasis treatment as part of a multicompany conglomerate led by Telormedix.
16-Sep-2013 - Theorem Clinical Research and CRL (Charles River Laboratories) have partnered to help clients transition between preclinical and clinical testing.
11-Sep-2013 - Synthesis Med Chem has opened a UK facility in an effort to win more pharma and biotech customers in Europe.
10-Sep-2013 - Covance’s IT expenses are expected to taper off in 2014, which could contribute to driving wider margins for the CRO, Covance CFO Alison Cornell said Monday.
09-Sep-2013 - The Clinical Trial Company has incorporated a new US business to meet the needs of its growing client and sponsor base.
05-Sep-2013 - Full-Service CRO PSI is expanding into Italy, South Africa and India as part of a push to gain a more global presence for clients.
04-Sep-2013 - UK CRO Selcia has been contracted to develop antibiotics capable of tacking resistant superbugs by Cantab Anti-Infectives.
04-Sep-2013 - Bioreliance has launched an updated version of its mutagenicity service after conducting studies that confirmed its Big Blue Mouse assay still meets OECD standards.
03-Sep-2013 - Biofocus says it is literally bringing its scientists closer together to aid its drug discovery services with a new 60,000 square foot facility in Cambridge, UK.
26-Aug-2013 - IMCD Group will promote APIs made by Italian firm FIS in territories in Eastern Europe and the Southern hemisphere under a new agreement.
26-Aug-2013 - Duke University will play contract research organisation (CRO) for clinical trials of a Parkinson’s disease treatment being developed by International Stem Cell Corp (ISCO).
26-Aug-2013 - Drug Discovery firm Evotec has extended its collaboration with the Jain Foundation focused on muscular dystrophy.
22-Aug-2013 - Covance has upgraded blood tube processing and kit production capabilities at its US central labs unit and says the efficiency drive is helping sponsors make better decisions.
22-Aug-2013 - Cutbacks are prompting more sponsors to outsource library design and screening during drug discovery according to UK-based software and consulting firm Cresset.